CoMind
The company develops non-invasive neurotechnology using photonics to monitor cerebral blood flow and other neurophysiological signals at the patient's bedside. Their technology provides clinicians with access to critical brain data without the need for invasive surgical procedures. The product is designed to optimize patient outcomes across the care continuum by providing a single, simplified measurement tool for doctors.
Visit websiteLondon, UK
Healthtech
Neurotechnology
Medical Devices
Photonics
Funding summary
- Total raised
- €86.3M
- Funding rounds
- 1
Investors in CoMind
Investors on record for CoMind. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like CoMind?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors